{"name":"Danish Oncological Lung Cancer Group","slug":"danish-oncological-lung-cancer-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOQU5sMHBjaFRod1lDZXljS3NldXlnWFcwdkxoNXF6bTNjSVVDdzFWSUM3SmtXcnpZTVJkSXRPbXhydWdsODN6TjlJN0VnQ0FneWVsZnl4VFRqZVhoSW9KMVJtemd0YVgxQXFnSUNPWUdpNlJMTUUzNHpVZ2JiSGlCek01ZjVuRkhmeDg4TDY2LUFiYVI4ZzZPVFIwczV3N1ZVQlh2TUFEMUFDYndXUTdlaXgyVDdHeURnSHBnbV9B?oc=5","date":"2026-03-20","type":"pipeline","source":"Oncology News Central","summary":"ADCs and More Take Center Stage at the 2026 European Lung Cancer Congress - Oncology News Central","headline":"ADCs and More Take Center Stage at the 2026 European Lung Cancer Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNaFZoaTk3c19rY0cwQmRITVFad1NPTDFlNVhZb24tSW8wUGdZVWhoMTVBeW5uMUYwbHJWcFhpZEFxRDJ0NTNoNllyRnAxbDNraGNOdU9jaUI2UDE2QXVlRGk1bWJKTEJSeHdoc2hieDl6SkJHQjJZUi0tLU9BQ2dhRzVaV1FuZmgzR3dQanJEX2hTZUI5T0Y0Qno3ZlJsTTRfbXFFcE41RTJUeFV0S2c?oc=5","date":"2026-02-10","type":"regulatory","source":"Pharmaceutical Technology","summary":"AstraZeneca bets on continued oncology demand for 2026 growth - Pharmaceutical Technology","headline":"AstraZeneca bets on continued oncology demand for 2026 growth","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-03","type":"trial","source":"Business Wire","summary":"Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into M","headline":"Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treate","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-11-20","type":"pipeline","source":"PR Newswire","summary":"Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanc","headline":"Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPelBYaUcwYnBQLUxWU3c2TnRRdDhGZVI1NDY5a0xaaXF3bWR2RWRBWVpkYlZaQkRtelBhOEZLdUE0eDNqdFkySmtCT2pkcnFaSGxhNDFPMEpNZkRfVWdwaHlrSTliSng3RmtUS0gwOUJlOFZWX3RraFlPMlJib0t4Sm5DMjZMR1VYR241SXJyTWFCalpqZnNqV2JNVnNPajFiaEVqOUZDa3JZYm1wQm5v?oc=5","date":"2025-08-12","type":"deal","source":"European Biotechnology Magazine","summary":"Bayer announces US$1.3bn oncology deal with Kumquat Biosciences - European Biotechnology Magazine","headline":"Bayer announces US$1.3bn oncology deal with Kumquat Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWlB0aFdBUlVFeXdQajZvUUVBZktrMGpKTUNfR0JIZE9hel91NlpzY2dzTUpDbWlzT1lUNlZIcWdnZ1RncjQyV190bHFoRmlOUmRKdjBuZ0VLUVRtR3FvS0Zsa1dZZW96WmhHMURFSVRBN0c0M3pCOGNMbXU5bjNTZWJVb3hQMWJ0R0lCTjdCbFZpM1Zvdld6U2NFc0g0OUVOS3ZVQzRCb0V0U2Fib2FNVU9yX2RXR3BQZFY3THlteTJPVU5SLVhlckxBaVFwd0hGaVp2X0liemZlXzdGYU9OMHYyc09HVFRWeXgxaw?oc=5","date":"2025-08-12","type":"deal","source":"PR Newswire","summary":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology - PR Newswire","headline":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBTMjZtbmgtRWs5TjkyNVk0NmxIRHZyMjBwYWlvRVdmS1FqWG5PNHRyVUNlZUs5Z3g2bEFBVEZZUGtxaDM3V3hEWTdhQXdOYUZ5MlRBcExRVXNFRkV2TE5EOEVpTWItQXczZHdyX1dfMVZnaEthWEZYcURMQ3o?oc=5","date":"2025-05-19","type":"pipeline","source":"Pharmaceutical Technology","summary":"Imagene's OI Suite: Revolutionizing Precision Oncology with AI-Driven Solutions - Pharmaceutical Technology","headline":"Imagene's OI Suite: Revolutionizing Precision Oncology with AI-Driven Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQVnpIbWMxdzdpeE0tT1BvaUp5b3F0ZHM1VjNZcXNhSExVandfaG53TU5Ld2hOdVhPTTVSWHlPT1ppYWNORVJCQ3RudFlaZFhaNUgybzluTlFNaC1ITGFuTjhuRHg4bVRyR2cwaFViX0wyVHhfc09sM2NES1NQbUpYMGphR3dubGtW?oc=5","date":"2025-04-21","type":"earnings","source":"fiercepharma.com","summary":"The top 20 pharma companies by 2024 revenue - fiercepharma.com","headline":"The top 20 pharma companies by 2024 revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBMbmNGeFo0dk9iWHdNY3N1Zm82cXp0bmlLaVU5UGhWdkhhOS16WE5NWVhlUmJMb04xeE5meWhXai1MRkNDcEpab3Exems4cW9DdkxpR2hWZ3NUV19fWmpURWd1X2JZUFNDbk5iNFBYdTc?oc=5","date":"2025-03-18","type":"pipeline","source":"Labiotech.eu","summary":"The hottest cancer vaccine companies you should know about - Labiotech.eu","headline":"The hottest cancer vaccine companies you should know about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNRTBoTWdzSDh3Um5VVjJBQUVVTFVSTTltcFFuRmpsa0drU0pKenRJaWVNblFPREx0RXpEandHZ1hsSVN2dTRBNXFfUm9QNzRPbDFaMkM2YkxFczhNakFyR3VzNjFrekx0MVZqT1hkUnAxSFUtMFYtLTAxeWVHd2dsZG5NNjRWQkVmRWhLaDBXay0xZkFEY3o4Y0xwYUlkRzE1Wk8tYXVtRlVEZUt0QU5QN2JqM0RhWHJNellmNzBvQ0lLRk01SHc?oc=5","date":"2025-02-19","type":"regulatory","source":"Boehringer Ingelheim","summary":"Zongertinib Priority Review FDA non-small cell lung cancer - Boehringer Ingelheim","headline":"Zongertinib Priority Review FDA non-small cell lung cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1NTmZoYXAtckMtdG85UFJsS0k2OE55MC03OGNGX0hodUlOc0dmc0R1MmFkVWJ3cUhLdlMzaXFadmI1Xy1Fd09mUDRXZzdNOEc3bFpTQ1ExZw?oc=5","date":"2024-12-10","type":"trial","source":"ASCO Publications","summary":"Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial - ASCO Publications","headline":"Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOSmd0NjhNMk9GeWxsbndablR5UWpaSUNMeC01N0c2Y0x0TlpsUlV6MjBYMEp3UngwN1J6eG96TDdTdHhmTDRWdVdrRUFxV2hmX01tc0xVbDJ2YzY2NzItb2VzMEdaU2dqMU5ibGY1WHRUTGR0VmgwTVNaeGJLQlZ0UlpnWHBxek5BX2dfNXpDUmktZmx4ZzJldDBmYUd0NmxkU2tDYV84WkYwUzZUNHowZ2x3?oc=5","date":"2024-12-09","type":"trial","source":"Clinical Trials Arena","summary":"Lantern Pharma starts dosing in Taiwan in non-smoker lung cancer trial - Clinical Trials Arena","headline":"Lantern Pharma starts dosing in Taiwan in non-smoker lung cancer trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}